SCHEMBL31456007

SCHEMBL31456007

CCCOc1cc(C=O)c(OC)cc1Br

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.57
ALDH1A1 P00352 6/20 0.53
KDM4E B2RXH2 1/20 0.53
TSHR P16473 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
LMNA P02545 3/20 0.53
HPGD P15428 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
PTPN1 P18031 4/20 0.46
ERN1 O75460 3/20 0.45
DPP4 P27487 1/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.41
HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16020892 0.86 PTPN1 (0.60) PRKDCALDH1A1KDM4ETSHRTDP1
SCHEMBL29771743 0.85 LMNA (0.49) PRKDCALDH1A1KDM4ETSHRTDP1
SCHEMBL29246738 0.85 LMNA (0.49) PRKDCALDH1A1KDM4ETSHRTDP1
SCHEMBL2037945 0.84 LMNA (0.56) PRKDCALDH1A1KDM4ETSHRTDP1
SCHEMBL2037836 0.83 PRKDC (0.74) PRKDCALDH1A1KDM4ETSHRTDP1
SCHEMBL2037716 0.83 LMNA (0.54) PRKDCALDH1A1KDM4ETSHRTDP1
SCHEMBL2038528 0.81 LMNA (0.53) PRKDCKDM4ELMNAPTPN1MEN1
SCHEMBL2040993 0.81 LMNA (0.53) PRKDCKDM4ELMNAPTPN1MEN1
SCHEMBL2037034 0.81 LMNA (0.53) PRKDCKDM4ELMNAPTPN1MEN1
SCHEMBL28648665 0.81 LMNA (0.48) PRKDCALDH1A1KDM4ETSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059373-A1 NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2025-03-20 WO disclosed